Flexor Tenosynovitis Due to Tuberculosis in Hand and Wrist: Is Tenosynovectomy Imperative? 2016

Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
From the *IST-EL Hand Surgery, Microsurgery and Rehabilitation; †Department of Orthopaedics and Traumatology, Şişli Hamidiye Etfal Education and Research Hospital; ‡Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpasa Hospital; §Department of Plastic and Reconstructive Surgery, Kartal Lütfi Kirdar Education and Research Hospital, Istanbul, Turkey.

The treatment of flexor tenosynovitis in the hand and wrist due to tuberculosis is controversial. Although some authors recommend the antituberculous chemotherapy, the others recommend the surgical treatment. In this article, 12 patients with synovial tuberculosis of the flexor aspect of the hand and the wrist were evaluated with respect to diagnosis and treatment modalities. None of the patients had a history of tuberculosis, concomitant disease, immunosuppressive drug use, drug abuse, and human immunodefficiency virus positivity. A chest x-ray and family screening were performed in all of the cases, none had evidence of tuberculosis in the lung. The biopsy, histopathological examination, acid-fast bacillus staining, and BACTEC tuberculosis culture were performed. Antituberculous chemotherapy was initiated in patients diagnosed with tuberculosis by either histological or microbiological examinations. The patients did not undergo any further surgery after biopsy procedures. The lesions regressed totally in all patients after 3 months of treatment. Carpal tunnel syndrome symptoms and signs recruited at five months of treatment. In patients with flexor tuberculosis tenosynovitis, it is possible to achieve good results by applying only medical therapy after a biopsy, and without the need for further surgery.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006225 Hand The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb. Hands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074402 Synovectomy Surgical removal of the SYNOVIAL MEMBRANE. Synovium Resection,Resection, Synovium,Synovectomies,Synovium Resections
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
January 2021, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
March 2023, BMJ case reports,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
April 2024, Cureus,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
August 2005, ANZ journal of surgery,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
December 1998, Journal of hand surgery (Edinburgh, Scotland),
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
September 2019, Tuberkuloz ve toraks,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
January 2000, Joint bone spine,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
April 2018, Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
December 2021, Hand surgery & rehabilitation,
Fatih Kabakaş, and Meriç Uğurlar, and Derya Bayirli Turan, and Nebil Yeşiloğlu, and Berkan Mersa, and İsmail Bülent Özçelik
January 2014, Acta orthopaedica et traumatologica turcica,
Copied contents to your clipboard!